XA-Novo: high-throughput mass spectrometry-based de novo sequencing technology for monoclonal antibodies and antibody mixtures

Posted on
xa-novo:-high-throughput-mass-spectrometry-based-de-novo-sequencing-technology-for-monoclonal-antibodies-and-antibody-mixtures
XA-Novo: high-throughput mass spectrometry-based de novo sequencing technology for monoclonal antibodies and antibody mixtures

References

  1. Lu, L. L., Suscovich, T. J., Fortune, S. M. & Alter, G. Beyond binding: antibody effector functions in infectious diseases. Nat. Rev. Immunol. 18, 46–61 (2018).

    Google Scholar 

  2. Oostindie, S. C., Lazar, G. A., Schuurman, J. & Parren, P. Avidity in antibody effector functions and biotherapeutic drug design. Nat. Rev. Drug Discov. 21, 715–735 (2022).

    Google Scholar 

  3. Watson, C. T., Glanville, J. & Marasco, W. A. The Individual and Population Genetics of Antibody Immunity. Trends Immunol. 38, 459–470 (2017).

    Google Scholar 

  4. Ejazi, S. A., Ghosh, S. & Ali, N. Antibody detection assays for COVID-19 diagnosis: an early overview. Immunol. Cell Biol. 99, 21–33 (2021).

    Google Scholar 

  5. Ning, L., Abagna, H. B., Jiang, Q., Liu, S. & Huang, J. Development and application of therapeutic antibodies against COVID-19. Int J. Biol. Sci. 17, 1486–1496 (2021).

    Google Scholar 

  6. Lu, R. M. et al. Development of therapeutic antibodies for the treatment of diseases. J. Biomed. Sci. 27, (2020).

  7. Mason, D. M. et al. Optimization of therapeutic antibodies by predicting antigen specificity from antibody sequence via deep learning. Nat. Biomed. Eng. 5, 600–612 (2021).

    Google Scholar 

  8. Mattsson, J. et al. Sequence enrichment profiles enable target-agnostic antibody generation for a broad range of antigens. Cell Rep. Methods 3, 100475 (2023).

    Google Scholar 

  9. Parray, H. A. et al. Hybridoma technology a versatile method for isolation of monoclonal antibodies, its applicability across species, limitations, advancement and future perspectives. Int Immunopharmacol. 85, 106639 (2020).

    Google Scholar 

  10. Tomita, M. & Tsumoto, K. Hybridoma technologies for antibody production. Immunotherapy 3, 371–380 (2011).

    Google Scholar 

  11. Subas et al. NAb-seq: an accurate, rapid, and cost-effective method for antibody long-read sequencing in hybridoma cell lines and single B cells. MAbs 14, 2106621 (2022).

    Google Scholar 

  12. Chen, Y. et al. Barcoded sequencing workflow for high throughput digitization of hybridoma antibody variable domain sequences. J. Immunol. Methods 455, 88–94 (2018).

    Google Scholar 

  13. Schardt, J. S., Sivaneri, N. S. & Tessier, P. M. Monoclonal antibody generation using single B-cell screening for treating infectious diseases. BioDrugs 38, 477–486 (2024).

    Google Scholar 

  14. de Graaf, S. C., Hoek, M., Tamara, S. & Heck, A. J. R. A perspective toward mass spectrometry-based de novo sequencing of endogenous antibodies. MAbs 14, 2079449 (2022).

    Google Scholar 

  15. Schulte, D., Peng, W. & Snijder, J. Template-based assembly of proteomic short reads for de novo antibody sequencing and repertoire profiling. Anal. Chem. 94, 10391–10399 (2022).

    Google Scholar 

  16. Le Bihan, T. et al. De novo protein sequencing of antibodies for identification of neutralizing antibodies in human plasma post SARS-CoV-2 vaccination. Nat. Commun. 15, 8790 (2024).

    Google Scholar 

  17. Sen, K. I. et al. Automated Antibody De Novo sequencing and its utility in biopharmaceutical discovery. J. AM Soc. Mass Spectr. 28, 803–810 (2017).

    Google Scholar 

  18. Gadush, M. V. et al. Template-Assisted De Novo Sequencing of SARS-CoV-2 and Influenza Monoclonal Antibodies By Mass Spectrometry. J. Proteome Res. 21, 1616–1627 (2022).

    Google Scholar 

  19. He, M.-T. et al. Do-It-Yourself De Novo Antibody Sequencing Workflow That Achieves Complete Accuracy Of The Variable Regions. J. Proteome Res. 24, 3062–3073 (2025).

    Google Scholar 

  20. Pinto, D. et al. Broad betacoronavirus neutralization by a stem helix-specific human antibody. Science 373, 1109–1116 (2021).

    Google Scholar 

  21. Ye, X. et al. Integrated proteomics sample preparation and fractionation: Method development and applications. Trends Anal. Chem. 120, 115667 (2019).

    Google Scholar 

  22. Tsiatsiani, L. & Heck, A. J. R. Proteomics beyond trypsin. FEBS J. 282, 2612–2626 (2015).

    Google Scholar 

  23. Morsa, D. et al. Multi-enzymatic limited digestion: the next-generation sequencing for proteomics? J. Proteome Res. 18, 2501–2513 (2019).

    Google Scholar 

  24. Yilmaz M., Fondrie W., Bittremieux W., Oh S., Noble W. S. De novo mass spectrometry peptide sequencing with a transformer model. Int. Conf. Mach. Learn. 162, 25514-25522 (2022).

  25. Yilmaz, M. et al. Sequence-to-sequence translation from mass spectra to peptides with a transformer model. Nat. Commun. 15, 6427 (2024).

    Google Scholar 

  26. Cao, Y. et al. BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection. Nature 608, 593–602 (2022).

    Google Scholar 

  27. Wu, Y. et al. Lineage-mosaic and mutation-patched spike proteins for broad-spectrum COVID-19 vaccine. Cell Host Microbe 30, 1732–1744.e1737 (2022).

    Google Scholar 

  28. Tran, N. H. et al. Complete De Novo assembly of monoclonal antibody sequences. Sci. Rep. 6, 31730 (2016).

    Google Scholar 

  29. Schulte, D. & Snijder, J. A Handle on Mass Coincidence Errors in De Novo sequencing of antibodies by bottom-up proteomics. J. Proteome Res. 23, 3552–3559 (2024).

    Google Scholar 

  30. Guthals, A. et al. De Novo MS/MS sequencing of native human antibodies. J. Proteome Res. 16, 45–54 (2017).

    Google Scholar 

  31. Guthals, A., Clauser, K. R., Frank, A. M. & Bandeira, N. Sequencing-Grade De novo Analysis of MS/MS Triplets (CID/HCD/ETD) From Overlapping Peptides. J. Proteome Res. 12, 2846–2857 (2013).

    Google Scholar 

  32. Peng, W. et al. Reverse-engineering the anti-MUC1 antibody 139H2 by mass spectrometry-based de novo sequencing. Life Sci. Alliance 7, e202302366 (2024).

    Google Scholar 

  33. Chen, D. S. & Mellman, I. Oncology meets immunology: the cancer-immunity cycle. Immunity 39, 1–10 (2013).

    Google Scholar 

  34. Zhao, Y. L. et al. Comparison of the characteristics of macrophages derived from murine spleen, peritoneal cavity, and bone marrow. J. Zhejiang Univ. Sci. B 18, 1055–1063 (2017).

    Google Scholar 

  35. Bronte, V. & Pittet, M. ikaelJ. The spleen in local and systemic regulation of immunity. Immunity 39, 806–818 (2013).

    Google Scholar 

  36. Khoury, D. S. et al. Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection. Nat. Med. 27, 1205–1211 (2021).

    Google Scholar 

  37. Cameroni, E. et al. Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift. Nature 602, 664–670 (2022).

    Google Scholar 

  38. Tortorici, M. A. et al. Broad sarbecovirus neutralization by a human monoclonal antibody. Nature 597, 103–108 (2021).

    Google Scholar 

  39. Copin, R. et al. The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies. Cell 184, 3949–3961.e3911 (2021).

    Google Scholar 

  40. Cao, Y. et al. Rational identification of potent and broad sarbecovirus-neutralizing antibody cocktails from SARS convalescents. Cell Rep. 41, 111845 (2022).

    Google Scholar 

  41. Wang, M. et al. Assembling the Community-Scale Discoverable Human Proteome. Cell Syst. 7, 412–421.e415 (2018).

    Google Scholar 

  42. Beslic, D., Tscheuschner, G., Renard, B. Y., Weller, M. G. & Muth, T. Comprehensive evaluation of peptide de novo sequencing tools for monoclonal antibody assembly. Brief. Bioinform. 24, bbac542 (2022).

    Google Scholar 

  43. Wen, B. & Noble, W. S. A multi-species benchmark for training and validating mass spectrometry proteomics machine learning models. Sci. Data 11, 1207 (2024).

    Google Scholar 

  44. Tran, N. H., Zhang, X., Xin, L., Shan, B. & Li, M. De novo peptide sequencing by deep learning. Proc. Natl. Acad. Sci. USA 114, 8247–8252 (2017).

    Google Scholar 

  45. Kessner, D., Chambers, M., Burke, R., Agus, D. & Mallick, P. ProteoWizard: open source software for rapid proteomics tools development. Bioinformatics 24, 2534–2536 (2008).

    Google Scholar 

  46. Needleman, S. B. & Wunsch, C. D. A general method applicable to the search for similarities in the amino acid sequence of two proteins. J. Mol. Biol. 48, 443–453 (1970).

    Google Scholar 

Download references